NCT02236715View on ClinicalTrials.gov

Postmarketing Surveillance Study of Atrovent® in Chronic Obstructive Airways Disease

CompletedOBSERVATIONAL
Enrollment

1,039

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

February 29, 2000

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Atrovent®

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY